-
1دورية أكاديمية
المؤلفون: Bellmunt, Joaquim, de Wit, Ronald, Vaughn, David J, Fradet, Yves, Lee, Jae-Lyun, Fong, Lawrence, Vogelzang, Nicholas J, Climent, Miguel A, Petrylak, Daniel P, Choueiri, Toni K, Necchi, Andrea, Gerritsen, Winald, Gurney, Howard, Quinn, David I, Culine, Stéphane, Sternberg, Cora N, Mai, Yabing, Poehlein, Christian H, Perini, Rodolfo F, Bajorin, Dean F
المصدر: New England Journal of Medicine. 376(11)
مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Immunology, Clinical Research, Cancer, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Docetaxel, Female, Humans, Male, Middle Aged, Neoplasm Recurrence, Local, Paclitaxel, Platinum Compounds, Programmed Cell Death 1 Receptor, Survival Analysis, Taxoids, Urologic Neoplasms, Urothelium, Vinblastine, KEYNOTE-045 Investigators, Medical and Health Sciences, General & Internal Medicine, Biomedical and clinical sciences, Health sciences
وصف الملف: application/pdf
الوصول الحر: https://escholarship.org/uc/item/9266k1mkTest
-
2دورية أكاديمية
المؤلفون: Balar, Arjun V1 arjun.balar@nyumc.org, Castellano, Daniel2, O'Donnell, Peter H3, Grivas, Petros4, Vuky, Jacqueline5, Powles, Thomas6, Plimack, Elizabeth R7, Hahn, Noah M8, de Wit, Ronald9, Pang, Lei10, Savage, Mary J10, Perini, Rodolfo F10, Keefe, Stephen M10, Bajorin, Dean11, Bellmunt, Joaquim12, O'Donnell, Peter H3
المصدر: Lancet Oncology. Nov2017, Vol. 18 Issue 11, p1483-1492. 10p.
مصطلحات موضوعية: *PEMBROLIZUMAB, *CISPLATIN, *UROTHELIUM, *CANCER treatment, *CANCER chemotherapy, *CANCER, *THERAPEUTIC use of monoclonal antibodies, *CANCER invasiveness, *CLINICAL trials, *COMPARATIVE studies, *DRUG administration, *DRUG dosage, *DOSE-effect relationship in pharmacology, *DRUG toxicity, *INTERNATIONAL relations, *INTRAVENOUS therapy, *LONGITUDINAL method, *RESEARCH methodology, *MEDICAL cooperation, *MONOCLONAL antibodies, *PATIENT safety, *PROGNOSIS, *RESEARCH, *SURVIVAL analysis (Biometry), *TUMOR classification, *URINARY organs, *EVALUATION research, *RANDOMIZED controlled trials, *TREATMENT effectiveness, *BLIND experiment, *TRANSITIONAL cell carcinoma, *TUMORS